Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Kaleem Khan, M.D.
Family Practice · NAPERVILLE, IL · NPI 1619917713
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 697 | 78 |
| Atorvastatin Calcium | Atorvastatin Calcium | 577 | 97 |
| Metoprolol Succinate | Metoprolol Succinate | 420 | 74 |
| Gabapentin | Gabapentin | 401 | 40 |
| Furosemide | Furosemide | 362 | 48 |
| Amlodipine Besylate | Amlodipine Besylate | 361 | 60 |
| Omeprazole | Omeprazole | 357 | 52 |
| Eliquis | Apixaban | 353 | 26 |
| Losartan Potassium | Losartan Potassium | 348 | 50 |
| Escitalopram Oxalate | Escitalopram Oxalate | 286 | 34 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 263 | 40 |
| Tamsulosin Hcl | Tamsulosin Hcl | 233 | 56 |
| Metoprolol Tartrate | Metoprolol Tartrate | 213 | 24 |
| Hydralazine Hcl | Hydralazine Hcl | 202 | 25 |
| Finasteride | Finasteride | 200 | 22 |
| Lisinopril | Lisinopril | 189 | 35 |
| Sertraline Hcl | Sertraline Hcl | 183 | 13 |
| Pantoprazole Sodium | Pantoprazole Sodium | 167 | 28 |
| Clopidogrel | Clopidogrel Bisulfate | 155 | 15 |
| Metformin Hcl | Metformin Hcl | 155 | 37 |
| Simvastatin | Simvastatin | 153 | 31 |
| Metformin Hcl Er | Metformin Hcl | 150 | 32 |
| Fluoxetine Hcl | Fluoxetine Hcl | 140 | suppressed |
| Bumetanide | Bumetanide | 131 | 11 |
| Potassium Chloride | Potassium Chloride | 125 | 27 |
| Carvedilol | Carvedilol | 120 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 116 | 21 |
| Mirtazapine | Mirtazapine | 116 | 15 |
| Allopurinol | Allopurinol | 114 | 20 |
| Divalproex Sodium Er | Divalproex Sodium | 102 | suppressed |
| Memantine Hcl | Memantine Hcl | 102 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 92 | 29 |
| Myrbetriq | Mirabegron | 92 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 90 | suppressed |
| Spironolactone | Spironolactone | 86 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 84 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 81 | 16 |
| Quetiapine Fumarate | Quetiapine Fumarate | 79 | 18 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 77 | 13 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 75 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 72 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 71 | 12 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 68 | 27 |
| Trazodone Hcl | Trazodone Hcl | 68 | 15 |
| Xarelto | Rivaroxaban | 68 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 67 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 66 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 64 | 16 |
| Ropinirole Hcl | Ropinirole Hcl | 62 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 59 | 16 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 59 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 56 | suppressed |
| Glipizide | Glipizide | 55 | 13 |
| Glipizide Er | Glipizide | 55 | 11 |
| Brilinta | Ticagrelor | 53 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 53 | 14 |
| Hydrochlorothiazide | Hydrochlorothiazide | 52 | 17 |
| Pravastatin Sodium | Pravastatin Sodium | 52 | 14 |
| Febuxostat | Febuxostat | 51 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 50 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 49 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 48 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 47 | suppressed |
| Prednisone | Prednisone | 47 | 38 |
| Torsemide | Torsemide | 45 | 14 |
| Glimepiride | Glimepiride | 44 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 44 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 43 | 31 |
| Jantoven | Warfarin Sodium | 41 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 40 | 13 |
| Ezetimibe | Ezetimibe | 39 | 11 |
| Alprazolam | Alprazolam | 37 | 14 |
| Atenolol | Atenolol | 37 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 35 | suppressed |
| Jardiance | Empagliflozin | 34 | suppressed |
| Azithromycin | Azithromycin | 32 | 27 |
| Diclofenac Sodium | Diclofenac Sodium | 32 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 30 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 29 | 19 |
| Scopolamine | Scopolamine | 29 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 28 | suppressed |
| Meloxicam | Meloxicam | 28 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 27 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 27 | 11 |
| Ozempic | Semaglutide | 27 | suppressed |
| Cephalexin | Cephalexin | 26 | 20 |
| Famotidine | Famotidine | 26 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 26 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 26 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 24 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 23 | 18 |
| Midodrine Hcl | Midodrine Hcl | 23 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 22 | 11 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 22 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 22 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 21 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 21 | suppressed |
| Alcohol Swabs | Alcohol Antiseptic Pads | 20 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 20 | suppressed |
| Januvia | Sitagliptin Phosphate | 20 | suppressed |
| Nystatin | Nystatin | 20 | 11 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 20 | suppressed |
| Primidone | Primidone | 20 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 20 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 19 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 19 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 18 | 12 |
| Klor-Con M20 | Potassium Chloride | 17 | suppressed |
| Trulicity | Dulaglutide | 17 | suppressed |
| Arformoterol Tartrate | Arformoterol Tartrate | 16 | suppressed |
| Entresto | Sacubitril/Valsartan | 16 | suppressed |
| Lamotrigine | Lamotrigine | 16 | suppressed |
| Levetiracetam | Levetiracetam | 16 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 16 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 16 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 15 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 15 | suppressed |
| Olanzapine | Olanzapine | 15 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 14 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 14 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 14 | suppressed |
| Diazepam | Diazepam | 14 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 14 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 14 | suppressed |
| Levofloxacin | Levofloxacin | 14 | 11 |
| Procrit | Epoetin Alfa | 14 | suppressed |
| Amoxicillin | Amoxicillin | 13 | 12 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 13 | 12 |
| Celecoxib | Celecoxib | 13 | suppressed |
| Hydrocortisone | Hydrocortisone | 13 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 13 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 13 | suppressed |
| Sodium Polystyrene Sulfonate | Sodium Polystyrene Sulfonate | 13 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 12 | suppressed |
| Metolazone | Metolazone | 12 | suppressed |
| Novolog | Insulin Aspart | 12 | suppressed |
| Pregabalin | Pregabalin | 12 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 11 | 11 |
| Azelastine Hcl | Azelastine Hcl | 11 | suppressed |
| Fenofibrate | Fenofibrate | 11 | suppressed |
| Haloperidol | Haloperidol | 11 | suppressed |
| Ibuprofen | Ibuprofen | 11 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 11 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Lovastatin | Lovastatin | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error